ORIGINAL RESEARCH
Published on 21 Nov 2025
LncRNA ELDR promotes bladder cancer malignant progression by regulating the miR-1343-3p/TRIM44 axis
doi 10.3389/fonc.2025.1685792
- 473 views
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Advancements in targeted therapies for genitourinary cancers
Advancements in targeted therapies for genitourinary cancers
1,206
Total downloads
9,130
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 13 Oct 2025
Efficacy and safety of apalutamide, abiraterone acetate, and bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer
doi 10.3389/fonc.2025.1656216
- 1,628 views
CASE REPORT
Published on 08 Sep 2025
Case report series: Pembrolizumab and enfortumab vedotin in plasmacytoid urothelial carcinoma
doi 10.3389/fonc.2025.1608291
- 1,793 views
REVIEW
Published on 03 Sep 2025
Mechanism of action of HMGB1 in urologic malignancies
doi 10.3389/fonc.2025.1593157
- 1,961 views
CASE REPORT
Published on 01 Aug 2025
Pembrolizumab for treatment-related neuroendocrine prostate carcinoma with a high tumor mutational burden: a case report
doi 10.3389/fonc.2025.1642412
- 1,385 views
Published in
Frontiers in Endocrinology
Cancer Endocrinology
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: